Subscribe To
Sirius xm clocks 8% revenue growth in fy21 backed by subscriber addons; declares special cash dividend
Sirius XM Holdings Inc SIRI reported FY21 revenue growth of 8% year-on-year to $8.7 billion. [LIVE NOW ON YOUTUBE] Click Here to Watch a FREE
February 1, 2022, 10:10 am
Biogen exercises option to participate developing genentech's bispecific antibody, mosunetuzumab
Biogen Inc BIIB has exercised its option to participate in the development and commercialization of mosunetuzumab, a CD20xCD3 T-cell engaging bispe...
February 1, 2022, 10:03 am
Biogen exercises option to participate developing genentech's bispecific antibody, mosunetuzumab
Biogen Inc BIIB has exercised its option to participate in the development and commercialization of mosunetuzumab, a CD20xCD3 T-cell engaging bispe...
February 1, 2022, 10:03 am
Biogen exercises option to participate developing genentech's bispecific antibody, mosunetuzumab
Biogen Inc BIIB has exercised its option to participate in the development and commercialization of mosunetuzumab, a CD20xCD3 T-cell engaging bispe...
February 1, 2022, 10:03 am
Anavex life sciences says rett syndrome trial meets primary & secondary goals
Anavex Life Sciences Corp AVXL reported topline data from the Phase 3 AVATAR trial of ANAVEX2-73 (blarcamesine) in adult female patients with Rett sy...
February 1, 2022, 9:38 am
Anavex life sciences says rett syndrome trial meets primary & secondary goals
Anavex Life Sciences Corp AVXL reported topline data from the Phase 3 AVATAR trial of ANAVEX2-73 (blarcamesine) in adult female patients with Rett sy...
February 1, 2022, 9:38 am
Anavex life sciences says rett syndrome trial meets primary & secondary goals
Anavex Life Sciences Corp AVXL reported topline data from the Phase 3 AVATAR trial of ANAVEX2-73 (blarcamesine) in adult female patients with Rett sy...
February 1, 2022, 9:38 am
Verano to acquire goodness growth holdings in $413m all-stock deal, scores license in nyc
Key Points [LIVE NOW ON YOUTUBE] Click Here to Watch a FREE masterclass on the Ultimate Bear Market Su...
February 1, 2022, 8:33 am
Verano to acquire goodness growth holdings in $413m all-stock deal, scores license in nyc
Key Points [LIVE NOW ON YOUTUBE] Click Here to Watch a FREE masterclass on the Ultimate Bear Market Su...
February 1, 2022, 8:33 am
Verano to acquire goodness growth holdings in $413m all-stock deal, scores license in nyc
Key Points [LIVE NOW ON YOUTUBE] Click Here to Watch a FREE masterclass on the Ultimate Bear Market Su...
February 1, 2022, 8:33 am
Catalent's q2 earnings beat street view, lifts fy22 guidance
Catalent Inc CTLT has reported Q2 FY22 sales of $1.22 billion, +34% Y/Y as reported, or 35% in constant currency, edging out analysts' average expec...
February 1, 2022, 8:14 am
Catalent's q2 earnings beat street view, lifts fy22 guidance
Catalent Inc CTLT has reported Q2 FY22 sales of $1.22 billion, +34% Y/Y as reported, or 35% in constant currency, edging out analysts' average expec...
February 1, 2022, 8:14 am
Catalent's q2 earnings beat street view, lifts fy22 guidance
Catalent Inc CTLT has reported Q2 FY22 sales of $1.22 billion, +34% Y/Y as reported, or 35% in constant currency, edging out analysts' average expec...
February 1, 2022, 8:14 am
Bio-techne clocks 17% organic revenue growth in q2, announces $400m share buyback
Bio-Techne Corporation TECH has posted Q2 FY22 sales of $269.3 million, up 20% Y/Y, beating the consensus of $266.57 million. [LIVE NOW ON YOUTUBE] ...
February 1, 2022, 7:03 am
Bio-techne clocks 17% organic revenue growth in q2, announces $400m share buyback
Bio-Techne Corporation TECH has posted Q2 FY22 sales of $269.3 million, up 20% Y/Y, beating the consensus of $266.57 million. [LIVE NOW ON YOUTUBE] ...
February 1, 2022, 7:03 am
Bio-techne clocks 17% organic revenue growth in q2, announces $400m share buyback
Bio-Techne Corporation TECH has posted Q2 FY22 sales of $269.3 million, up 20% Y/Y, beating the consensus of $266.57 million. [LIVE NOW ON YOUTUBE] ...
February 1, 2022, 7:03 am
Ups stock surges post q4 earnings beat, solid fy22 outlook
United Parcel Service, Inc. UPS reported fourth-quarter FY21 revenue growth of 11.5% year-over-year to $27.77 billion, beating the consensus of $27...
February 1, 2022, 7:02 am
Ups stock surges post q4 earnings beat, solid fy22 outlook
United Parcel Service, Inc. UPS reported fourth-quarter FY21 revenue growth of 11.5% year-over-year to $27.77 billion, beating the consensus of $27...
February 1, 2022, 7:02 am
Ups stock surges post q4 earnings beat, solid fy22 outlook
United Parcel Service, Inc. UPS reported fourth-quarter FY21 revenue growth of 11.5% year-over-year to $27.77 billion, beating the consensus of $27...
February 1, 2022, 7:02 am
Sio gene terminates parkinson's gene therapy pact with oxford biomedica, announces ceo transition
Sio Gene Therapies Inc SIOX has decided to terminate its licensing agreement with Oxford Biomedica for AXO-Lenti-PD, its lentiviral gene therapy...
February 1, 2022, 5:51 am